CXCL9 and melanoma: Specifically, pro-inflammatory CXCL9<sup>+</sup>CXCL10<sup>+</sup> TAMs are enriched in SCC, while tissue-remodelling SPP1<sup>+</sup> TAMs are predominant in melanoma.